Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Endocyte Inc (ECYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Help

Go To:

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

Previous Next

	12-2012	12-2011	12-2010	12-2009	12-2008
Assets
Current Assets
Cash & Cash Equivalents	33,997	61,353	16,873	8,699	N/A
Marketable Securities	141,841	66,732	0	15,210	N/A
Receivables	5,689	N/A	N/A	N/A	N/A
Other current assets	498	548	540	0	0
TOTAL	$184,825	$129,756	$20,050	$24,283	$N/A

Non-Current Assets
PPE Net	3,167	1,108	863	923	N/A
Investments And Advances	25,541	0	0	0	0
Other Non-Current Assets	546	811	301	61	0
TOTAL	$29,254	$1,919	$1,164	$985	$N/A

Total Assets	$214,079	$131,675	$21,214	$25,268	$N/A

Liabilities
Current Liabilities
Short Term Debt	N/A	N/A	4,318	6,258	N/A
Accounts payable and accrued liabilities	3,648	2,126	755	1,790	0
Accrued Expenses	6,816	3,345	1,601	538	N/A
Other current liabilities	13	N/A	999	221	N/A
TOTAL	$62,470	$5,470	$7,673	$8,807	$N/A

Non-Current Liabilities
Long Term Debt	N/A	12,833	20,653	2,719	N/A
Deferred Revenues	51,993	N/A	N/A	N/A	N/A
Other Non-Current Liabilities	42	0	89,800	89,800	0
TOTAL	$52,035	$12,833	$110,452	$92,518	$N/A

Total Liabilities	$114,505	$18,303	$118,125	$101,325	$N/A

Shareholders' Equity
Shares Outstanding, K	35,926	35,793	N/A	N/A	N/A
Common Shares	36	36	1	1,916	N/A
Retained earnings	-155,892	-138,601	-98,069	-77,976	N/A
Other shareholders' equity	73	-6	0	2	0
TOTAL	$99,573	$113,372	$-96,911	$-76,058	$N/A

Total Liabilities And Equity	$214,079	$131,675	$21,214	$25,268	$0